Clinical Trial Update: Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Plitidepsin (Aplidin) in combination with bortezomib and dexamethasone in multiple myeloma patients who are double refractory to bort…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Plitidepsin (Aplidin) (plitidepsin)

Snippet

Sponsor: PharmaMar | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2020-12-02